|
1
|
Cortini M, Avnet S and Baldini N:
Mesenchymal stroma: Role in osteosarcoma progression. Cancer Lett.
405:90–99. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Picci P: Osteosarcoma (Osteogenic
sarcoma). Orphanet J Rare Dis. 2:62007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Mckenna WG, Barnes MM, Kinsella TJ,
Rosenberg SA, Lack EE and Glatstein E: Combined modality treatment
of adult soft tissue sarcomas of the head and neck. Int J Radiat
Oncol Biol Phys. 13:1127–1133. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chen X, Bahrami A, Pappo A, Easton J,
Dalton J, Hedlund E, Ellison D, Shurtleff S, Wu G, Wei L, et al:
Recurrent somatic structural variations contribute to tumorigenesis
in pediatric osteosarcoma. Cell Rep. 7:104–112. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lian H, Xie P, Yin N, Zhang J, Zhang X, Li
J and Zhang C: Linc00460 promotes osteosarcoma progression via
miR-1224-5p/FADS1 axis. Life Sci. 233:1167572019. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kim W, Han I, Lee JS, Cho HS, Park JW and
Kim HS: Postmetastasis survival in high-grade extremity
osteosarcoma: A retrospective analysis of prognostic factors in 126
patients. J Surg Oncol. 117:1223–1231. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Fellenberg J, Bernd L, Delling G, Witte D
and Zahlten- Hinguranage A: Prognostic significance of
drug-regulated genes in high-grade osteosarcoma. Mod Pathol.
20:1085–1094. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Piperno-Neumann S, Ray-Coquard I, Occean
BV, Laurence V, Cupissol D, Perrin C, Penel N, Bompas E, Rios M, Le
Cesne A, et al: Results of API-AI based regimen in osteosarcoma
adult patients included in the French OS2006/Sarcome-09 study. Int
J Cancer. 146:413–423. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wen J, Qin Y, Li C, Dai X, Wu T and Yin W:
Mangiferin suppresses human metastatic osteosarcoma cell growth by
down-regulating the expression of metalloproteinases-1/2 and
parathyroid hormone receptor 1. AMB Express. 10:132020. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhang Z, Zhao M and Wang G:
Hsa_circ_0051079 functions as an oncogene by regulating
miR-26a-5p/TGF-β1 in osteosarcoma. Cell Biosci. 9:942019.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Spizzo R, Almeida MI, Colombatti A and
Calin GA: Long non-coding RNAs and cancer: A new frontier of
translational research? Oncogene. 31:4577–4587. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yang X, Xie X, Xiao YF, Xie R, Hu CJ, Tang
B, Li BS and Yang SM: The emergence of long non-coding RNAs in the
tumorigenesis of hepatocellular carcinoma. Cancer Lett.
360:119–124. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Liu Y, Zhang R and Ying K: Long non-coding
RNAs: Novel links in respiratory diseases (review). Mol Med Rep.
11:4025–4031. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yi S, Xiao-jiang Y, Zhen-jun L, Gang L,
Wu-jin X and Wei-xia J: UCA1, a long noncoding RNA, promotes the
proliferation of CRC cells via p53/p21 signaling. Open Life Sci.
11:206–210. 2016. View Article : Google Scholar
|
|
15
|
Maruyama R and Suzuki H: Long noncoding
RNA involvement in cancer. BMB Rep. 45:604–611. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Li Z, Yu X and Shen J: Long non-coding
RNAs: Emerging players in osteosarcoma. Tumor Biol. 37:2811–2816.
2016. View Article : Google Scholar
|
|
17
|
Sun J, Wang X, Fu C, Wang X, Zou J, Hua H
and Bi Z: Long noncoding RNA FGFR3-AS1 promotes osteosarcoma growth
through regulating its natural antisense transcript FGFR3. Mol Biol
Rep. 43:427–436. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ruan W, Wang P, Feng S, Xue Y and Li Y:
Long non-coding RNA small nucleolar RNA host gene 12 (SNHG12)
promotes cell proliferation and migration by upregulating
angiomotin gene expression in human osteosarcoma cells. Tumor Biol.
37:4065–4073. 2016. View Article : Google Scholar
|
|
19
|
Li T, Mo X, Fu L, Xiao B and Guo J:
Molecular mechanisms of long noncoding RNAs on gastric cancer.
Oncotarget. 7:8601–8612. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Li LJ, Zhu JL, Bao WS, Chen DK, Huang WW
and Weng ZL: Long noncoding RNA GHET1 promotes the development of
bladder cancer. Int J Clin Exp Pathol. 7:7196–7205. 2014.PubMed/NCBI
|
|
21
|
Yang F, Xue X, Zheng L, Bi J, Zhou Y, Zhi
K, Gu Y and Fang G: Long non-coding RNA GHET1 promotes gastric
carcinoma cell proliferation by increasing c-Myc mRNA stability.
FEBS J. 281:802–813. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhou J, Li X, Wu M, Lin C, Guo Y and Tian
B: Knockdown of long noncoding RNA GHET1 inhibits cell
proliferation and invasion of colorectal cancer. Oncol Res.
23:303–309. 2016. View Article : Google Scholar
|
|
23
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Pastushenko I and Blanpain C: EMT
transition states during tumor progression and metastasis. Trends
Cell Biol. 29:212–226. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Huang R and Zong X: Aberrant cancer
metabolism in epithelial- mesenchymal transition and cancer
metastasis: Mechanisms in cancer progression. Crit Rev Oncol
Hematol. 115:13–22. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Mittal V: Epithelial mesenchymal
transition in tumor metastasis. Annu Rev Pathol. 13:395–412. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wittig JC, Bickels J, Priebat D, Jelinek
J, Kellar-Graney K, Shmookler B and Malawer MM: Osteosarcoma: A
multidisciplinary approach to diagnosis and treatment. Am Fam
Physician. 65:1123–1132. 2002.PubMed/NCBI
|
|
28
|
Isakoff MS, Bielack SS, Meltzer P and
Gorlick R: Osteosarcoma: Current treatment and a collaborative
pathway to success. J Clin Oncol. 33:3029–3035. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhang T, Li J, Yin F, Lin B, Wang Z, Xu J,
Wang H, Zuo D, Wang G, Hua Y and Cai Z: Toosendanin demonstrates
promising antitumor efficacy in osteosarcoma by targeting STAT3.
Oncogene. 36:6627–6639. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Liu X, Xiu LJ, Jiao JP, Zhao J, Zhao Y, Lu
Y, Shi J, Li YJ, Ye M, Gu YF, et al: Traditional Chinese medicine
integrated with chemotherapy for stage IV non-surgical gastric
cancer: A retrospective clinical analysis. J Integr Med.
15:469–475. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zang QQ, Zhang L, Gao N and Huang C:
Ophiopogonin D inhibits cell proliferation, causes cell cycle
arrest at G2/M, and induces apoptosis in human breast carcinoma
MCF-7 cells. J Integr Med. 14:51–59. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Chen LL and Zhao JC: Functional analysis
of long noncoding RNAs in development and disease. Adv Exp Med
Biol. 825:129–158. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Hajjari M, Khoshnevisan A and Shin YK:
Molecular function and regulation of long non-coding RNAs:
Paradigms with potential roles in cancer. Tumour Biol.
35:10645–10663. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Gupta RA, Nilay S, Wang KC, Kim J,
Horlings HM, Wong DJ, Tsai MC, Hung T, Argani P, Rinn JL, et al:
Long non-coding RNA HOTAIR reprograms chromatin state to promote
cancer metastasis. Nature. 464:1071–1076. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Takayama K, Horie-Inoue K, Katayama S,
Suzuki T, Tsutsumi S, Ikeda K, Urano T, Fujimura T, Takagi K,
Takahashi S, et al: Androgen-responsive long noncoding RNA CTBP1-AS
promotes prostate cancer. EMBO J. 32:1665–1680. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Zhao H, Zhang K, Wang T, Cui J, Xi H, Wang
Y, Song Y, Zhao X, Wei B and Chen L: Long non-coding RNA
AFAP1-antisense RNA 1 promotes the proliferation, migration and
invasion of gastric cancer cells and is associated with poor
patient survival. Oncol Lett. 15:8620–8626. 2018.PubMed/NCBI
|
|
37
|
Ernst C and Morton CC: Identification and
function of long non-coding RNA. Front Cell Neurosci. 7:1682013.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Wang KC and Chang HY: Molecular mechanisms
of long noncoding RNAs. Mol Cell. 43:904–914. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Tam WL and Weinberg RA: The epigenetics of
epithelial-mesenchymal plasticity in cancer. Nat Med. 19:1438–1449.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Van Der Steen N, Honeywell RJ, Dekker H,
Van Meerloo J, Kole J, Musters R, Ruijtenbeek R, Rolfo C, Pauwels
P, Peters GJ and Giovannetti G: Resistance to crizotinib in a cMET
gene amplified tumor cell line is associated with impaired
sequestration of crizotinib in lysosomes. J Mol Clin Med. 1:99–106.
2018.
|
|
41
|
Liu H, Zhao J and Lv J: Inhibitory effects
of miR-101 overexpression on cervical cancer SiHa cells. Eur J
Gynaecol Oncol. 38:236–240. 2017.PubMed/NCBI
|
|
42
|
Hu H, Zhang G, Tian G, Lv G and Jin Y:
miRNA profiling reveals the upregulation of osteogenesis-associated
miRNAs in ovariectomy osteoporosis mice. Clin Exp Obstet Gynecol.
45:817–822. 2018.
|
|
43
|
Pan JJ and Yang MH: The role of
epithelial-mesenchymal transition in pancreatic cancer. J
Gastrointest Oncol. 2:151–156. 2011.PubMed/NCBI
|
|
44
|
Gonzalez DM and Damian M: Signaling
mechanisms of the epithelial-mesenchymal transition. Sci Signal.
7:re82014. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Ye X and Weinberg RA:
Epithelial-mesenchymal plasticity: A central regulator of cancer
progression. Trends Cell Biol. 25:675–686. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Nieto MA: Epithelial plasticity: A common
theme in embryonic and cancer cells. Science. 342:12348502013.
View Article : Google Scholar : PubMed/NCBI
|
